Effect of Evolocumab on Coronary Plaque Characteristics
NCT04710368
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
137
Enrollment
OTHER
Sponsor class
Conditions
Coronary Artery Disease
Interventions
DRUG:
Evolocumab Injections
Sponsor
Annapoorna Kini